Overview
CEN ISO/TS 20451:2026, titled “Health informatics - Identification of medicinal products - Implementation for ISO 11616 data elements and structures for the unique identification and exchange of regulated pharmaceutical product information,” is a technical specification developed by CEN. The document provides essential requirements and recommendations for the unique identification and exchange of regulated pharmaceutical product information, aligning with the core principles of ISO 11616. The main focus is to ensure precise pharmaceutical product identification (PhPID) and interoperability among stakeholders, such as regulatory authorities, healthcare providers, and information system vendors, within the framework of global health informatics standards.
Key Topics
- Unique Identification of Pharmaceutical Products: Guidance on associating pharmaceutical products with correct PhPID(s) as defined by a medicines regulatory authority.
- ISO 11616 Implementation: Practical requirements for representing ISO 11616 data elements and structures in electronic health records, regulatory submissions, and pharmaceutical product databases.
- Data Elements and Structures: Emphasis on identifying characteristics such as active substances, strengths, dose forms, medical devices, and specified substances.
- Strata and Levels of Identification: Specification of two main PhPID strata-active substance stratum and specified substance stratum-each with four levels for detailed granularity (from substances only to substance plus strength, form, and device).
- Integration with Existing Standards: References to ISO 11238, ISO 11239, ISO 11240, ISO 11615, as well as HL7 V3 messaging models and HL7 FHIR, ensuring compatibility with established informatics and regulatory infrastructure.
- Cardinality and Data Relationships: Clear specification of how data elements interrelate (e.g., one or more substances per product, presentation forms, and device associations).
Applications
The practical application of CEN ISO/TS 20451:2026 is key in modern healthcare and regulatory contexts, including:
- Regulatory Compliance: Supports pharmaceutical companies and regulatory authorities in creating and managing electronic submissions for product approvals based on harmonized identifiers.
- Health Information Exchange: Enables interoperability and data exchange between electronic health records (EHR), pharmacy systems, and national/regional drug databases, improving patient safety and data consistency.
- Pharmacovigilance and Traceability: Facilitates global monitoring and traceability of medicinal products through standardized identifiers, essential for recalls, adverse event reporting, and lifecycle management.
- Clinical Decision Support: Provides accurate and unambiguous product identification for clinical software applications, reducing medication errors and enhancing decision-making.
- Cross-Border Healthcare: Assists in the exchange of pharmaceutical product information across jurisdictions, essential for international coordination and compliance with global regulatory trends.
Related Standards
To maximize implementation effectiveness and compatibility, CEN ISO/TS 20451:2026 should be considered alongside the following standards:
- ISO 11616: Core standard for data elements and structures for the unique identification and exchange of regulated pharmaceutical product information.
- ISO 11238: Data elements and structures for the unique identification of regulated substances.
- ISO 11239: Information on pharmaceutical dose forms, units of presentation, routes of administration, and packaging.
- ISO 11240: Standard for the unique identification and exchange of units of measurement.
- ISO 11615: Specification for the unique identification of regulated medicinal product information.
- ISO/TS 19844, ISO/TS 20440, ISO/TS 20443: Technical specifications offering implementation guidelines for the above ISO standards.
- HL7 Messaging Standards (V3 RIM, CPM, SPL, FHIR): Essential information models for electronic health data and pharmaceutical product information exchange.
Summary
Adopting CEN ISO/TS 20451:2026 ensures a harmonized, interoperable approach to uniquely identifying and exchanging pharmaceutical product data in regulated environments. The technical specification underpins regulatory submissions, patient safety initiatives, and global health information exchange. Its integration with existing ISO and HL7 standards enhances data quality, traceability, and reliability across the pharmaceutical and healthcare sectors. This makes it an essential tool for stakeholders seeking efficiency and compliance in the increasingly digital health informatics landscape.